Acetoacetate is a trigger of NLRP3 inflammasome activation in bovine peripheral blood mononuclear cells

被引:6
作者
Onizawa, Yuri [1 ]
Katoh, Taiga [1 ]
Miura, Ryotaro [2 ]
Konda, Kunitoshi [3 ]
Noguchi, Tatsuo [4 ]
Iwata, Hisataka [1 ]
Kuwayama, Takehito [1 ]
Hamano, Seizo [5 ]
Shirasuna, Koumei [1 ]
机构
[1] Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa 2430034, Japan
[2] Nippon Vet & Life Sci Univ, Dept Vet Med, Musashino, Tokyo 1808602, Japan
[3] Kanagawa Prefectural Livestock Ind Technol Ctr, Ebina, Kanagawa 2430417, Japan
[4] Tokyo Univ Agr, Univ Farm, Shizuoka 4180109, Japan
[5] Artificial Inseminat Assoc Japan, Shinagawa Ku, Tokyo 1350041, Japan
关键词
Acetoacetate; beta-hydroxybutyrate; NLRP3; inflammasome; Repeat breeder cows; BETA-HYDROXYBUTYRATE; DAIRY-COWS; MECHANISM; ENDOMETRIUM; METABOLITE; EXPRESSION; PREGNANCY; CYTOKINES; IMMUNITY; DENSITY;
D O I
10.1016/j.vetimm.2021.110370
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Repeat breeding, which is non-pregnancy following three or more breeding attempts, is a serious reproductive disorder in cattle. In the present study, metabolomic profiling was used to identify metabolites in the blood plasma of repeat breeder cows (RBCs) and non-RBCs. Metabolomic analysis showed that acetoacetate (AcAc), a ketone body, was detected in RBCs, but not in non-RBCs. In contrast, beta-hydroxybutyrate (BHB) was at similar levels in both RBCs and non-RBCs. We hypothesized that an imbalance of AcAc and BHB induces abnormal inflammatory conditions, especially the NLRP3 inflammasome, which regulates sterile inflammation to control interleukin (IL)-1 beta secretion, and may be associated with repeat breeding in cattle. To investigate this hypothesis, blood samples were collected from both non-RBCs and RBCs on day 7 of the estrous cycle. The mRNA expression of IL1B in peripheral blood mononuclear cells (PBMCs) was observed to be higher in RBCs than in non-RBCs. To test the effects of AcAc and BHB on inflammatory responses, blood samples were collected from healthy cows and PBMCs were isolated. PBMCs were treated with AcAc and BHB to investigate the activation of the NLRP3 inflammasome (complex of NLRP3, ASC, and caspase-1) and IL-1 beta secretion. AcAc treatment resulted in higher protein and/or mRNA expression of NLRP3 and IL-1 beta in PBMCs. Moreover, AcAc increased the co-localization of NLRP3 and ASC and stimulated caspase-1 activation, indicating the formation of the platform of the NLRP3 inflammasome. Addition of specific NLRP3 inhibitor, MCC950, suppressed AcAc stimulation-induced IL-1 beta secretion. Contrary to the effects of AcAc, BHB treatment suppressed the activation of NLRP3 inflammasome and IL-1 beta secretion in response to AcAc and typical NLRP3 inflammasome triggers. These findings demonstrate that AcAc can potentially trigger NLRP3 inflammasome activation, resulting in IL-1 beta secretion, and that these in-flammatory responses are suppressed by BHB in bovine PBMCs. In addition, the imbalance between AcAc and BHB with higher levels of IL-1 beta may be associated with repeat breeding in cattle.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] NLRP3 inflammasome in peripheral blood monocytes as a risk factor for early -onset preeclampsia
    Yang, Hong
    Ai, Mo
    Guo, Yanqiu
    Li, Bingfen
    Liu, Cong
    Qu, Dongying
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [32] Silica induces NLRP3 inflammasome activation in human lung epithelial cells
    Peeters, Paul M.
    Perkins, Timothy N.
    Wouters, Emiel F. M.
    Mossman, Brooke T.
    Reynaert, Niki L.
    PARTICLE AND FIBRE TOXICOLOGY, 2013, 10
  • [33] Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
    Iyer, Shankar S.
    Pulskens, Wilco P.
    Sadler, Jeffrey J.
    Butter, Loes M.
    Teske, Gwendoline J.
    Ulland, Tyler K.
    Eisenbarth, Stephanie C.
    Florquin, Sandrine
    Flavell, Richard A.
    Leemans, Jaklien C.
    Sutterwala, Fayyaz S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) : 20388 - 20393
  • [34] Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction
    Chevriaux, Angelique
    Pilot, Thomas
    Derangere, Valentin
    Simonin, Harmonie
    Martine, Pierre
    Chalmin, Fanny
    Ghiringhelli, Francois
    Rebe, Cedric
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [35] Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation
    Hwang, Seonhwa
    Park, Min-Seo
    Koo, Anthony Junhoe
    Yoo, Eunsoo
    Song, Seh-Hyon
    Kim, Hye-Kyung
    Park, Min-Hi
    Kang, Jae-Seon
    BIOMOLECULES, 2024, 14 (10)
  • [36] Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
    de Jesus, Joyce de Cassia Rosa
    Murari, Ariene Soares de Pinho
    Radloff, Katrin
    de Moraes, Ruan Carlos Macedo
    Figueredo, Raquel Galvao
    Pessoa, Ana Flavia Marcal
    Rosa-Neto, Jose Cesar
    Matos-Neto, Emidio Marques
    Alcantara, Paulo S. M.
    Tokeshi, Flavio
    Maximiano, Linda Ferreira
    Bin, Fang Chia
    Formiga, Fernanda Bellotti
    Otoch, Jose P.
    Seelaender, Marilia
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [37] Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: A narrative review
    Neudorf, Helena
    Little, Jonathan P.
    BIOMEDICAL JOURNAL, 2024, 47 (01)
  • [38] Seasonal coronavirus infections trigger NLRP3 inflammasome activation in macrophages but is therapeutically targetable
    Li, Yang
    Wang, Yining
    Li, Yunlong
    de Vries, Annemarie C.
    Li, Pengfei
    Peppelenbosch, Maikel P.
    Pan, Qiuwei
    ANTIVIRAL RESEARCH, 2023, 216
  • [39] The NLRP3 Inflammasome as a Pharmacological Target
    Marchetti, Carlo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (04) : 285 - 296
  • [40] NLRP3 Inflammasome in the Pathogenesis of Miscarriages
    Omeljaniuk, Wioleta Justyna
    Garley, Marzena
    Pryczynicz, Anna
    Motyka, Joanna
    Charkiewicz, Angelika Edyta
    Milewska, Elzbieta
    Laudanski, Piotr
    Miltyk, Wojciech
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)